Oxides of Nitrogen

Total Page:16

File Type:pdf, Size:1020Kb

Oxides of Nitrogen This report contains the collective vews of an international group of experts and does not necce- sarilv represent the decisions or the stated policy of eaher the World hle;ilth Organization or the United Nations Environment Programme EnvironmentQ/ Health Criteria 4 OXIDES OF NITROGEN Published under the joint sponsorship of the United Nations Environment Programme and the Wodd Health Organization World Health Organization 1 '- Geneva, 1977 I, . 7. ISBN 92 4 154063 X t World 1-Icaith Organization 1977 Publications of the World I-Iealth Organization enjoy copyright protection in accordance with the provisions of Protocol 2 of the Universal Copyright Convention. For rights of reproduction or translation of WHO publications, in part or in lob, application should he made to the Office of Publications, World Health Organization, Geneva, Switzerland. The World Health Organization welcomes such applications. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the Secretariat of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. PRINTLD iN UNITED KiNtiDUM CONTEJV TS Page FNVIRONMJN1AL HEALTH (RliF-RIA FOR OXIDISOF - NITROGEN 9 I. SUMMARY ANt) RF.C(JMMFNDATIONS FOR FURTHER RF.SFAR( II 10 1.1 Suniniirv 10 I. Li (hcrnitrs• andanalyvcal niethixIs ...... I)) I 2 Sources of I) S ides of riltroge n ............. I U 1.1 3 F.nvii'unmental levels and exposure' ............ 1 11.4 [fleets on experilnental anitiials .......... 12 1. I .5 Effects us man ................ I 3 1.5.1 ( 'ontrolled exposures ............ 13 1.15.2 Accklciltiil arid IliluStriLil cxpssures ....... 14 .1.53 (immunity exposures ............ 14 1.1.6 F.vuluation of health risks ................ 15 1.2 Recommendations for further research ............ 16 2. CHEMISTRY AND ANALYTICAL M[1HODS .......... 17 2.1 Chemical and phxsical properties ................I? Atmospheric uhenissii" ... ............. 19 2 3 Anaistical methods ... ............. .20 2.3 I Sampling .................20 2.3,2 E:iluationoliisilyicul melhods ............20 2.3.2.1 Maflual methods ...............21 13,2.Aulonis0ic methods ...... ......22 2.3.3 Calibration procedures SOURCES OF OXIDFS OF NITROGEN 3.1 Natural sources .....................24 3,3 Man-made sources .... ...............24 3.2 I Slationars smmarccs, ,....,.. ,,,,, 32.3 MohiI sources .................... 26 3.2.3 Non-combustion sources .................26 1.24 Other sources ....................20 ENVIRONMENTAL I.EVELS AND EXPOSURES .......... 26 4. 1 Background concentrations ................26 4.2 Urban concentrations ..................27 4.3 Indoor exposure 31 4.4 Smoking ...... ..................13 - 5. EFFECTS ON F.XPERIMI1NTAI. ANIMALS .,,,....,.... 5.1 local effects on the respiratory ss steni . 33 1.1 Morphological chungs ............... 5.1.2 Functional changes... .............1 5 .f 3 Biochemical cllccts ... 16S 3 Page 5.2 Other effectc g 5.2.1 Effects on growth and body weight 52.2 Immunological effects .. ...... ........ ..38 5.2. 3 1-luematological effects ....... ........ ...39 52.4 Miscellaneous biochemical effects ...... ....... 40 5.15 F.ffects on reprod uction ... ..... .......... 41 5.2.6 Effects on the central nervous system ..... ...... 41 5.2,7 Behavioural changes ..... ..... ........ 42 5.2.8 C'arcinogcnicHy, mutagenicity and teratogenicity ........ 42 5.3 Interaction of nitrogen dioxide and infectious agents ... ...... 43 5,4 Sununars' table .... ....... ...... ...... 45 FEFEC'3'SON MAN .......................... 45 61 Controlled exposures ........... ...... .... 45 6.2 Accidental and industrial exposures .... ............ St 6.3 Community exposures ...... ................ 54 6.3.1 Effects on pulmonary function .. ...............54 6.3.2 Effects on the incidence of acute rcsp]rator disease ........ 55 6.33 Effects on the prevalence of chronic respiratory disease 6.4 Summary tables ..... ....... ....... .... 60 EVALUATION OF l-IEALTI-1 RiSKS FROM EXPOSURE '10 OXII)ES OF NITROGEN ........ ....... ........... 65 7.1 Exposure levels ....... ...... ........... 65 7.2 Experimenial animal studies ... .............. 66 7.3 ....... Controlled studies in man ....... ..... 67 7.4 Fffecs of accidental and industrial exposures ..... ...... 67 7.5 Effects of community exposures ......... ...... 68 7.6 Evaluation of health risks ......... ...... ..... 69 REFERENCES ...... ..... ....... ...... 71 4 NOTE TO READERS OF THE CRiTERIA DOCUMENTS While every effort has been made to present information in the criteria documents as accurately as possible without unduly delaying their publication, mistakes might have occurred and are likely to occur in the future. In the interest of all users of the environmental health criteria documents, readers are kindly requested to communicate any errors found to the Division of Environmental Health, World Health Organization, Geneva. Switzerland, in order that they may be included in corrigenda which will appear in subsequent volumes. In addition, experts in any particular field dealt with in the criteria documents are kindly requested to make available to the WHO Secretariat any important published information that may have inadvertently been omitted and which may change the evaluation of health risks from exposure to the environmental agent under exami- nation, so that information may be considered in the event of updating and re-evaluating the conclusions contained in the criteria documents. S WHO TASK GROUP ON ENViRONMENTAL HEALTH CRITERIA FOR OXIDES OF NITROGEN Tokro, 23 27 August 1976 'S Participants ,,li 'i/s'r.v Dr K. Riersteker, Medical Research Division, Municipal Health Department, Rotterdeni. Nether! and Professor K. A- Butueva. Department of Community Hygiene, Central Institute for Advanced Mcdical Training, Moscow, USSR Dr R. G. Derwent. Environmental and Medical Sciences Division. Atomic Energy Research Establishment, Hirwell, England Professor L. F-riherg. Department of Environmental Hygiene, 1 he Karolinska Institute, Stockholm. Sweden (Ciiuirn,an) Dr D. F.. Gardner, Biomedical Research Branch, Clinical Studies Division, Health Effects Research Laboratory, Environmental Protection Agency. Research Triangle Park, N C USA (Raiportiur) Dr J. .kiger. Centre of General and Environmental Hygiene. Institute of hygiene and Epidemiology. Praguc, Ciechoslovakia Dr 1. N akajima, Division of Eovironniental Health Research, Osaka Prefeciural Institute of Public I-Ieilih, Osaka. Japan I Vi(i'-Chairnian) Dr U. von Nieding. Luhoratoriuni for Atinung und Kreislauf, K runkeiihuus Bethan]en. Moers, Federal Republic of German', Mr F. A Schuck. US Environmental Protection Agency, Environmental Monitoring and Support laboratory, Las Vegas. NV. lISA (?f'.si'riers Dr J - Kagasva. Department of Medicine, Tokai University, Kanagawa, Japan Profesw)r K Maedi. Department of Medicine, Tokyo University. Tokyo. Japan Dr I. Okila. Department of Community Environmental Sciences, The Institute of Public II cal t h . Tok yo. J apa H Dr H - Watariahe. 11yogo Prefectural Institute of Public Health. K ohe, Japan Professor N. Yamaki. Faculty of Engineering. Saitama University, Saitama, Japan Dr N. Yamate, First Section of Fnvironmental Chemistry. National Institute of hygienic Sciences. Tokyo, Japan 7 Dr C. Freeman. Department 01 Medical Sciences, Stanford Resarcli Institute, Menlo Park, CA, IJ Si\ (lcrniiorarj Athco'rj Dr Y. Hascgawii, Medical Officer. Control of Environmental Pollution and llatards, World Health Organiiation, Geneva, Switierland 4501, Mr G ()i.olins. Scientist, ('ontrol of Environmental Pollution and Ha7ards, World Heullh Organization. Geneva, Switzerland (Seiretari) Professor C M. Shy, Institute for Environmental Studies and Department of F.pide- rr iology, School of Public Health, University of' North Carolina, Chapel Hill, NC, USA (Teniporari Athiaer) Dii. S'uiuki. The Institale of Public Health, Tokyo, Japan (Temporary Athio'r) Professor T. Toyarnii, Department of' Prcvenlive Medicine, Keio University, Tokyo. Japan ('[emporari A thoa'r) ENVIRONMENTAL HEAL TH CRITERIA FOR OXIDES OF NITROGEN . A WHO Task Group on Environmental Health Criteria for Oxides of Nitrogen met in Tokyo from 23 to 27 August 1976. Dr Y. Hasegawa, Medical Officer, Control of Environmental Pollution and Hazards, Division of Environmental Health, WHO, opened the meeting on behalf of the Director-General and expressed the appreciation of the Orga- nization to the Government of Japan for kindly acting as host to the meeting. In reply the group was welcomed by Dr M. Hashimoto, Director-General of the Air Quality Bureau, Environment Agency, Japan. The Task Group reviewed and revised the second draft criteria document and made an evaluation of the health risks from exposure to oxides of nitrogen. The first and second drafts of the criteria document were prepared by Dr C. Freeman, Director. Department of Medical Sciences, Stanford Research Institute, Menlo Park, CA, USA. The comments on which the second draft was based were received from the national focal points for the WHO
Recommended publications
  • Investigating the Role of Heme Oxygenase and Oxidative Stress in Oesophagogastric Cancer
    Investigating the Role of Heme Oxygenase and Oxidative Stress in Oesophagogastric Cancer Oliver Hartwell Priest Department of Surgery and Cancer Imperial College London St Mary’s Campus London, UK A thesis submitted to Imperial College London for the degree of Doctorate of Philosophy Supervisors Professor George Hanna Department of Surgery and Cancer, Imperial College London St Mary’s Campus, London, UK Dr Nandor Marczin Department of Anaesthetics, Pain Medicine and Intensive Care Imperial College London, Chelsea and Westminster Campus, London, UK 2 ABSTRACT Background: Molecular mechanisms underlying gastric and oesophageal cancer include alterations in growth factors, cytokines and cell adhesion molecules. Heme oxygenase (HO) enzyme catalyses the degradation of heme and generates bilirubin and carbon monoxide that have antioxidant, anti-inflammatory and anti-apoptotic activities. HO enzyme is implicated in the biology of cancer by its effects on cell growth and resistance to apoptosis. The roles of HO-1 and HO-2 enzymes in cancer cell growth are poorly understood, with reports suggesting both anti-inflammatory, anti-tumour effects and tumour-protective mechanisms mediated by HO activity. The role of HO-2 in inflammation and cancer is largely unexplored. Further understanding the influence of the HO enzyme system may provide improved novel targets for oesophagogastric cancer therapy. Materials and Methods: The primary objective of the thesis was to characterise the role of the heme oxygenase pathway and modulation of HO activity in upper gastrointestinal cancer cell growth in vitro. Cell culture techniques included MTT growth assay, Western blotting protein analysis, pharmacological modulation of HO activity and targeted knockdown of HO mRNA.
    [Show full text]
  • Formation of Zinc Protoporphyrin Ix During the Production Process of Dry Fermented Sausages
    FORMATION OF ZINC PROTOPORPHYRIN IX DURING THE PRODUCTION PROCESS OF DRY FERMENTED SAUSAGES H. De Maere1,2*, E. De Mey2, L. Dewulf², H. Paelinck², S. Chollet1 and I. Fraeye² 1 Food Quality Laboratory, Groupe ISA, Lille Cedex, France 2 Research Group for Technology and Quality of Animal Products, KAHO, Ghent, Belgium, member of Leuven Food Science and Nutrition Research Centre (LFoRCe), KULeuven, Leuven, Belgium Abstract – The aim of this study was to follow the stable red colour without any addition of nitrite or formation of zinc protoporphyrin IX (ZPP) during nitrate. Wakamatsu et al. [6] [7] assigned the the production process of dry fermented sausages. bright red colour of Parma ham to the presence of Three batches were made, with the addition of zinc protoporphyrin IX (ZPP), wherein the ferrous nitrite salt, sodium chloride or sea salt, respectively. ion in the heme molecule is replaced by zinc. The formation of ZPP was largely inhibited by nitrite during production of dry fermented sausages. Three possible formation pathways have been In nitrite-free dry fermented sausages ZPP was suggested, (i) a slow non-enzymatic reaction; (ii) a formed during production. In this study, the use of bacterial enzymatic reaction, and (iii) an sea salt had a positive effect on the formation of ZPP, enzymatic reaction where an endogenous especially during the fermentation period. ferrochelatase interchanges the two metals Fe(II) and Zn(II) [8] [9]. Key Words – ZPP, Colour, Sodium nitrite, Sea salt ZPP is also present in other meat products such as the Spanish Iberian ham, lacking nitrite or nitrate I.
    [Show full text]
  • Quo Vadis Porphyrin Chemistry?
    Physiol. Res. 55 (Suppl. 2): S3-S26, 2006 Quo vadis porphyrin chemistry? V. KRÁL1,2* J. KRÁLOVÁ3, R. KAPLÁNEK1,4, T. BŘÍZA1,4, P. MARTÁSEK4* 1Department of Analytical Chemistry, Institute of Chemical Technology, 2Zentiva R & D, 3Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, 4First Medical Faculty, Charles University, Prague, Czech Republic Received March 22, 2006 Accepted June 23, 2006 Summary This review summarizes recent developments in the area of porphyrin chemistry in the direction of biological applications. Novel synthetic methodologies are reviewed for porphyrin synthesis, porphyrin analog synthesis, stable porphyrinogens - calixpyrroles, expanded porphyrins. Unique biological properties of those compounds are desribed with focus on photodynamic therapy (PDT) and molecular recognition properties. Special attentions given to metalloporphyrins with potential to affect heme degradation and CO formation. Key words Porphyrins • Synthesis • Expanded porphyrins • Photosenzitizers • Molecular recognition • Metalloporphyrins 1. Porphyrin skelet in nature enzymes that are evolutionarily conserved from bacteria to humans. Naturally occuring porphyrins are synthesized Hem is ferroprotoporphyrin complex. The basis by living matter. Among the best known natural of the structure is the porphyrin skelet, which is formed structures utilizing porphyrin skelet are vitamin B12 by four pyrroles linked with four methine bridges. The (Fig. 1), chlorophyll (Fig. 3), uroporphyrins, substituents, four methyls, two vinyls and two propionic coproporphyrins and heme (Fig. 2). side chains, in beta positions of pyrroles, can be arranged In the natural system, vitamin B12 is known to by fifteenth modality, but only one of these isomers, have a contracted porphyrin framework which is known called Protoporphyrin IX, is present in living systems.
    [Show full text]
  • Journal Pre-Proof
    Journal Pre-proof The requirement for cobalt in vitamin B12: A paradigm for protein metalation Deenah Osman, Anastasia Cooke, Tessa R. Young, Evelyne Deery, Nigel J. Robinson, Martin J. Warren PII: S0167-4889(20)30254-8 DOI: https://doi.org/10.1016/j.bbamcr.2020.118896 Reference: BBAMCR 118896 To appear in: BBA - Molecular Cell Research Received date: 8 July 2020 Revised date: 13 October 2020 Accepted date: 14 October 2020 Please cite this article as: D. Osman, A. Cooke, T.R. Young, et al., The requirement for cobalt in vitamin B12: A paradigm for protein metalation, BBA - Molecular Cell Research (2020), https://doi.org/10.1016/j.bbamcr.2020.118896 This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. © 2020 Published by Elsevier. Journal Pre-proof The requirement for cobalt in vitamin B12: A paradigm for protein metalation Deenah Osmana, b, Anastasia Cookec, Tessa R. Younga, b, Evelyne Deeryc, Nigel J. Robinsona,b, Martin J. Warrenc, d, e, aDepartment of Biosciences, Durham University, Durham, DH1 3LE, UK. bDepartment of Chemistry, Durham University, Durham, DH1 3LE, UK.
    [Show full text]
  • Toxicological Profile for Lead/Metals Division
    LEAD 415 9. REFERENCES Abadin HG, Hibbs BF, Pohl HR. 1997b. Breast-feeding exposure of infants to cadmium, lead, and mercury: A public health viewpoint. Toxicol Ind Health 15(4):1-24. Abadin HG, Wheeler JS, Jones DE, et al. 1997a. A framework to guide public health assessment decisions at lead sites. J Clean Technol Environ Toxicol Occup Med 6:225-237. Abbate C, Buceti R, Munao F, et al. 1995. Neurotoxicity induced by lead levels: An electrophysiological study. Int Arch Occup Environ Health 66:389-392. ACGIH. 1986. Documentation of the threshold limit values and biological exposure indices. 5th ed. Cincinnati, OH: American Conference of Governmental Industrial Hygienists, BEI-19 to BEI-23. ACGIH. 1998. 1998 TLVs and BEIs. Threshold limit values for chemical substances and physical agents. Biological exposure indices. Cincinnati, OH: American Conference of Governmental Industrial Hygienist. ACGIH. 2004. Lead. Threshold limit values for chemical substances and physical agents and biological exposure indices. Cincinnati, OH: American Conference of Governmental Industrial Hygienists. Adebonojo FO. 1974. Hematologic status of urban black children in Philadelphia: Emphasis on the frequency of anemia and elevated blood lead levels. Clin Pediatr 13:874-888. Adhikari N, Sinha N, Narayan R, et al. 2001. Lead-induced cell death in testes of young rats. J Appl Toxicol 21:275-277. Adinolfi M. 1985. The development of the human blood-CSF-brain barrier. Dev Med Child Neurol 27:532-537. Agency for Toxic Substances and Disease Registry. 1989. Decision guide for identifying substance- specific data needs related to toxicological profiles; notice. Fed Regist 54(174):37618-37634.
    [Show full text]
  • Structural and Functional Analysis of GUN4 and Chlh Subunits of the Magnesium Chelatase Enzyme
    Structural and functional analysis of GUN4 and ChlH subunits of the magnesium chelatase enzyme by Shabnam Tarahi Tabrizi This thesis is presented for the award of the degree of Doctor of Philosophy Department of Chemistry and Biomolecular Sciences Faculty of Science and Engineering Macquarie University, Sydney, New South Wales 2109, Australia February 2016 Table of Contents Declaration .................................................................................................................................. 8 Acknowledgements ..................................................................................................................... 9 Abstract ..................................................................................................................................... 11 List of publications ................................................................................................................... 12 Conference presentation (*Oral presentations) ......................................................................... 14 Awards ...................................................................................................................................... 15 Abbreviations ............................................................................................................................ 16 Chapter 1. Introduction ............................................................................................................. 19 1.1 Photosynthesis ...............................................................................................................
    [Show full text]
  • Non-Invasive Detection of Iron Deficiency by Fluorescence
    ARTICLE Received 2 Jul 2015 | Accepted 18 Jan 2016 | Published 17 Feb 2016 DOI: 10.1038/ncomms10776 OPEN Non-invasive detection of iron deficiency by fluorescence measurement of erythrocyte zinc protoporphyrin in the lip Georg Hennig1,*, Christian Homann1,*, Ilknur Teksan2, Uwe Hasbargen2, Stephan Hasmu¨ller2, Lesca M. Holdt3, Nadia Khaled4, Ronald Sroka1, Thomas Stauch5, Herbert Stepp1, Michael Vogeser3 & Gary M. Brittenham6 Worldwide, more individuals have iron deficiency than any other health problem. Most of those affected are unaware of their lack of iron, in part because detection of iron deficiency has required a blood sample. Here we report a non-invasive method to optically measure an established indicator of iron status, red blood cell zinc protoporphyrin, in the microcirculation of the lower lip. An optical fibre probe is used to illuminate the lip and acquire fluorescence emission spectra in B1 min. Dual-wavelength excitation with spectral fitting is used to dis- tinguish the faint zinc protoporphyrin fluorescence from the much greater tissue background fluorescence, providing immediate results. In 56 women, 35 of whom were iron-deficient, the sensitivity and specificity of optical non-invasive detection of iron deficiency were 97% and 90%, respectively. This fluorescence method potentially provides a rapid, easy to use means for point-of-care screening for iron deficiency in resource-limited settings lacking laboratory infrastructure. 1 Laser-Forschungslabor, LIFE-Zentrum, Klinikum der Universita¨tMu¨nchen, Feodor-Lynen-Strasse 19, 81377 Munich, Germany. 2 Perinatalzentrum Grohadern, Klinikum der Universita¨tMu¨nchen, Marchioninistrasse 15, 81377 Munich, Germany. 3 Institut fu¨r Laboratoriumsmedizin, Klinikum der Universita¨t Mu¨nchen, Marchioninistrasse 15, 81377 Munich, Germany.
    [Show full text]
  • 1974 (Including Covering Contaminated Soil With
    P.1 1974 (including covering contaminated soil with ofthe lead associated with oat tops was directly at­ clean soil and reducing smelter emissions) and tributable to automobile (aerosol) emissions, but it brought about a decrease in blood lead levels that did not distinguish between lead in the edible por­ were measured a year later. The details ofthe blood tion (grain) and lead on the hulls or chaff.27 This lead levels and their significance are presented in same study reported that lettuce grown in the Salinas Chapter 12. The conclusion to be drawn from this Valley had 3 to 25 ppm lead (dry weight) associated study (and from the similar studies referred to with it, whereas the soil lead content was only 10 above) is that people who live in the vicinity ofa ma­ ppm. The lead content in the lettuce was reported to jor industrial source of lead (e.g., a smelter) are ex­ be 0.15 to 1.5 ppm on a fresh weight basis. The posed to abnormally high lead concentrations. limited data accumulated were used to deduce that the excess lead was delivered to the lettuce by aerial 7.4 DIETARY EXPOSURES emission from autos, and that removal of lead from 7.4.1 Food automobile exhaust would reduce the lead content 27 The route by which most people receive the of the lettuce by as much as 80 percent. In other largest portion of their daily lead intake is through areas, the contribution would be smaller. Though foods, with estimates ofthe daily dietary lead intake these figures may be accurate, they are based on for adult males ranging from 100 to 500 /Ag/day.26 some rather tenuous assumptions that are not well Only a fraction of this ingested lead is absorbed, as supported by observation and very limited data.
    [Show full text]
  • Induction of Aminolevulinic Acid Synthase Gene Expression and Enhancement of Metabolite, Protoporphyrin IX, Excretion by Organic Germanium
    European Journal of Pharmacology 653 (2011) 75–81 Contents lists available at ScienceDirect European Journal of Pharmacology journal homepage: www.elsevier.com/locate/ejphar Pulmonary, Gastrointestinal and Urogenital Pharmacology Induction of aminolevulinic acid synthase gene expression and enhancement of metabolite, protoporphyrin IX, excretion by organic germanium Takashi Nakamura a,⁎, Miki Saito a, Yasuhiro Shimada a, Haruhiko Fukaya b, Yasuo Shida b, Yoshihiko Tokuji c a Asai Germanium Research Institute Co., Ltd., Hakodate, Hokkaido, Japan b Tokyo University of Pharmacy and Life Sciences, Hachioji, Tokyo, Japan c Department of Agricultural and Life Science, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Hokkaido, Japan article info abstract Article history: Poly-trans-[(2-carboxyethyl) germasesquioxane], Ge-132 is a water-soluble organic germanium compound. Received 1 October 2010 Oral intake of dietary Ge-132 changes fecal color and we attempted to identify the fecal red pigment, which Received in revised form 3 December 2010 increased by the intake of dietary Ge-132. Sprague Dawley rats were given diets containing Ge-132 from 0 to Accepted 7 December 2010 0.5% concentration. Fecal red pigment was extracted and purified for optical and structural studies. We Available online 15 December 2010 examined the fecal red pigment content by high performance liquid chromatography (HPLC), and hepatic gene expressions relating to heme synthesis by reverse transcription polymerase chain reaction (RT-PCR). The Keywords: fi – Organic germanium puri ed red pigment had particular optical characteristics on the ultraviolet (UV) visible spectrum (Soret Ge-132 band absorbance at 400 nm) and fluorescence emission at 600 nm by 400 nm excitation, and was identified as Hepatic function protoporphyrin IX by LC-MS analysis.
    [Show full text]
  • Switching Metalloporphyrin Binding Specificity of a B-Type Cytochrome to Fluorogenic Zinc by Design
    bioRxiv preprint doi: https://doi.org/10.1101/832923; this version posted November 6, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Switching metalloporphyrin binding specificity of a b-type cytochrome to fluorogenic zinc by design. B. J. Bowena, A. R. McGarritya, J-Y. A. Szetoa, C. R. Pudneyb, D. D. Jonesa* a. School of Bioscience, Molecular Biosciences Division, Cardiff University, Cardiff, UK. b. Department of Biology and Biochemistry, University of Bath, Bath, UK. Supporting information is at the end of the main manuscript. Designed 60 interactions 50 +cyt b ZnPP 40 562 30 20 10 ZnPP Emission Intensity 0 570 600 630 660 690 Wavelength (nm) Abstract Metalloporphyrins play important roles in areas ranging from biology to nanoscience. Biology uses a narrow set of metal centres comprising mainly of iron and magnesium. Here, we convert metalloporphyrin specificity of cytochrome b562 from iron (haem) to fluorogenic zinc protoporphyrin IX (ZnPP). Through a computationally guided iterative design process, a variant with a near total preference for ZnPP was generated representing a switch in specificity. The new variant greatly enhanced (≥60 fold) the negligible aqueous fluorescence of free ZnPP in vitro and in vivo. 1 bioRxiv preprint doi: https://doi.org/10.1101/832923; this version posted November 6, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Introduction Here, we describe how an iterative design process can change the metalloporphyrin specificity of cytochrome b562 (cyt b562), a b-type haem binding protein unit, from iron to fluorogenic and photochemically active zinc.
    [Show full text]
  • In Vitro Inhibition of Adult Rat Intestinal Heme Oxygenase by Metalloporphyrinsl
    003 I-3998/89/2604-0362$02.00/0 PEDIATRIC RESEARCH Vol. 26, No. 4, 1989 Copyright O 1989 International Pediatric Research Foundation, Inc. Printed in U.S.A. In Vitro Inhibition of Adult Rat Intestinal Heme Oxygenase by Metalloporphyrinsl HENDRIK J. VREMAN, MICHAEL J. GILLMAN. AND DAVID K. STEVENSON Department of Pediatrics, Stanford University School of Medicine, Stanford California 94305 ABSTRACT. We determined the inhibitory effects of con- and oxidizes the a-methene bridge of the heme molecule, yielding centrations of tin- and zinc protoporphyrin (1-100 pM) CO, iron, and biliverdin in equimolar amounts (1). Biliverdin is and mesoporphyrin (0.1-10 pM) on the in vitro heme rapidly converted to bilirubin by the enzyme biliverdin reductase. oxygenase (HO) (E.C.1.14.99.3) activity in liver, spleen, SnPP and ZnPP, synthetic heme analogs (Fig. l), have been and intestine 13, 000 % g tissue supernatants from fasted shown to be effective in lowering serum bilirubin levels in a wide adult male Wistar rats through measurement of carbon range of animal species (2-8), by competitively inhibiting heme monoxide by gas chromatography. All four metallopor- oxygenase activity (7-10). Additionally, SnMP and ZnMP have phyrins inhibited intestinal HO, under the light-limited recently been found to be equally effective at about 10-fold lower conditions of these experiments. The zinc porphyrins doses (1 1, 12). showed a clear concentration dependency over the entire Previous studies have shown that heme is excreted into the range, reducing activity to near zero levels at their highest bile of SnPP-treated adult rats (13, 14).
    [Show full text]
  • Light-Chemical Energy Conversion Study of Reconstituted Zinc-Protoporphyrin/Zinc- Carboxyphenylethynyl Porphyrin Myoglobin Mutants
    國 立 交 通 大 學 生物科技研究所 碩士論文 利用重組鋅-原紫質及鋅-乙炔苯酸紫質 之不同肌紅蛋白突變株進行其光能轉化 學能的研究 Light-Chemical Energy Conversion Study of Reconstituted Zinc-Protoporphyrin/Zinc- Carboxyphenylethynyl Porphyrin Myoglobin Mutants 研究生:歐書涵 指導教授:吳東昆 博士 中華民國九十九年七月 利用重組鋅-原紫質及鋅-乙炔苯酸紫質之不同肌紅蛋白突變 株進行其光能轉化學能的研究 Light-Chemical Energy Conversion Study of Reconstituted Zinc-Protoporphyrin/Zinc- Carboxyphenylethynyl Porphyrin Myoglobin Mutants 研究生:歐書涵 Student: Shu-Han Ou 指導教授:吳東昆 博士 Advisor: Prof. Tung-Kung Wu Ph.D 國 立 交 通 大 學 生物科技研究所 碩士論文 A Manuscript of Dissertation Submitted to Department of Biological Science and Technology College of Biological Science and Technology National Chiao Tung University in partial Fulfillment of the Requirements for the Degree of Master of Philosophy in Biological Science and Technology Hsinchu, Taiwan, Republic of China July, 2010 中華民國九十九年七月 利用重組鋅-原紫質及鋅-乙炔苯酸紫質之不同肌紅蛋白突變 株進行其光能轉化學能的研究 中文摘要 經過定點突變的技術,可以將野生型肌紅蛋白 His-64、Val-68、Ile-107 分別 突變成 Asp、Leu、Met。研究指出,經突變的肌紅蛋白具有下列兩種特性:(1) 過氧化酶活性,(2) 能夠穩定帶有自由基的陽離子 (FeIV = O Por+‧),進而延長電 荷分離的時間。肌紅蛋白的結構已經藉由高解析 X-ray 解出,且基本特性也已分 析完成,因此肌紅蛋白很適合用來當作電子轉移以及化學活性分析的模型。為了 將野生型及突變型肌紅蛋白(MbWT,MbH64D, MbV68L, MbI107M, MbH64D/V68L, MbH64D/V68L/I107M) 應用在以蛋白質為基礎的光-化學能量轉換的系統中及比較其 突變的影響,因此,我們將輔基團 鋅-原紫質 (ZnPP) 以及 鋅-乙炔苯酸紫質 (ZnPE1) 重組到肌紅蛋白內。藉由紫外光-可見光光譜及螢光光譜分析其生物物 理特性以確定輔基團成功地重組到蛋白質的活性中心,並藉此算出其能隙 (energy gap)。此外,我們也經由循環伏安法及微差脈衝伏安法求出重組金屬紫質 -肌紅蛋白複合體的 HOMO/LUMO 電位。在螢光生命期的比較中發現,將輔基 團重組到肌紅蛋白內的生命期比單獨輔基團溶解在四氫呋喃 (THF) 內還要長。 以蛋白質為基礎的光化學能量轉換的系統包含重組金屬紫質-肌紅蛋白複合體當 做感光酵素、三乙醇胺 (TEA) 當作電子提供者以及菸鹼胺腺呤雙核酸磷酸鹽 (NADP+) 當作電子接受者。比較不同輔基團以及突變點的重組金屬紫質-肌紅蛋 V68L + 白複合體中,ZnPE1-Mb 具有最好的 NADP 還原效率 (94.7%) 以及連續照光 6 小時的反應速率 (0.209 mM/hr)。 I Light-Chemical Energy Conversion Study of Reconstituted Zinc-Protoporphyrin/Zinc- Carboxyphenylethynyl Porphyrin Myoglobin Mutants Abstract After replacing His 64 with Asp, Val 68 with Leu, and Ilu 107 with Met of myoglobin (Mb) via molecular engineering, two properties exist: (1) peroxidase activity and (2) the ferryl porphyrin cation radical (FeIV = O Por+‧) stabilization for prolonging charge separation.
    [Show full text]